欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD38 mAbs

简要描述:

MU1053 binds an epitope close to the C-terminal region of CD38. The residues composing this epitope are: N120, K121, F135, Q139, M142, D202, V203, H205, Q236, T237, E239, W241, Q272, S274, K276, I278, F284, C287, V288, P291, E292, S294, C296.

产品参数:

Cat. No.:MABL-909

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:crystallography, therapeutic, FC

详细介绍

Key features and details


Cat. No.

MABL-909

Name

Anti-CD38 mAbs

Clone No.

AFD-MU1053

From

Recombinant Antibody

Isotype

Engineer antibody

Application

crystallography, therapeutic, FC

Species Reactivity

Human

Basic Information


Specificity

MU1053 binds an epitope close to the   C-terminal region of CD38. The residues composing this epitope are: N120,   K121, F135, Q139, M142, D202, V203, H205, Q236, T237, E239, W241, Q272, S274,   K276, I278, F284, C287, V288, P291, E292, S294, C296.

Alternative Name

Cluster of Differentiation 38;  ADP-Ribosyl Cyclase 1; ADPRC1; ADPRC 1; 2-Phospho-Cyclic-ADP-Ribose   Transferase; Cyclic ADP-Ribose Hydrolase 1; 2-Phospho-ADP-Ribosyl Cyclase;   NAD(+) Nucleosidase; ADP-Ribose Transferase; Ecto-Nicotinamide Adenine   Dinucleoti

UniProt

P28907

Immunogen

The C-terminal domain of human CD38   (residue 45–300) was expressed and produced in a yeast expression system. The  purified recombinant protein was used as an antigen to immunize llamas. Phage   display technology was used to obtain positive clones against CD38.

Application Notes

The nanobody MU1053 has been   crystallised with CD38, and has been used to target molecules to CD38.   Tagging the nanobody with fluorescent proteins allows the quantification of   CD38 expression by flow cytometry, which can be used to identify malignant   multiple myeloma cells, which have higher CD38 expression. Further, a form of   MU1053 conjugated to a toxin has been developed as a potential therapeutic   agent to selectively kill CD38+ cells.

Antibody First Published

 Li et al. Immuno-targeting the   multifunctional CD38 using nanobody. Sci Rep. 2016 Jun   2;6:27057 PMID:27251575

Note on publication

Describes increased CD38 expression   in malignant cells and its potential as a drug target for cancer therapy.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD38 mAbs

下一篇: Anti-CD38 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号